

[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
[ Wed, Nov 22nd 2023
] - WOPRAI
Paul Matteis Reiterated (VRTX) at Hold and Held Target at $373 on, Nov 22nd, 2023
Paul Matteis of Stifel, Reiterated "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold and Held Target at $373 on, Nov 22nd, 2023.
Paul has made no other calls on VRTX in the last 4 months.
There are 15 other peers that have a rating on VRTX. Out of the 15 peers that are also analyzing VRTX, 3 agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $364 on, Wednesday, November 8th, 2023
- Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $347 on, Tuesday, November 7th, 2023
- Whitney Ijem of "Canaccord Genuity" Maintained at Hold with Increased Target to $315 on, Monday, August 7th, 2023
These are the ratings of the 12 analyists that currently disagree with Paul
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $380 on, Thursday, November 16th, 2023
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $390 on, Tuesday, November 7th, 2023
- Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $415 on, Tuesday, November 7th, 2023
- Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $370 on, Tuesday, October 17th, 2023
- Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $456 on, Wednesday, October 4th, 2023
- William Pickering of "Bernstein" Maintained at Buy with Increased Target to $390 on, Wednesday, August 2nd, 2023
- Phil Nadeau of "TD Cowen" Maintained at Buy with Increased Target to $370 on, Wednesday, August 2nd, 2023
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $399 on, Wednesday, August 2nd, 2023
- Hartaj Singh of "Oppenheimer" Reiterated at Buy and Held Target at $410 on, Wednesday, August 2nd, 2023
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $425 on, Wednesday, August 2nd, 2023
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $245 on, Tuesday, August 1st, 2023
- Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $424 on, Monday, July 24th, 2023
Contributing Sources